 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 06/13/2025 |
$0.41 |
$0.44 |
$0.40 |
$0.41 |
163.00K | | 06/16/2025 |
$0.41 |
$0.41 |
$0.38 |
$0.39 |
219.80K | | 06/17/2025 |
$0.41 |
$0.41 |
$0.38 |
$0.38 |
294.70K | | 06/18/2025 |
$0.38 |
$0.41 |
$0.38 |
$0.39 |
163.80K | | 06/20/2025 |
$0.40 |
$0.40 |
$0.38 |
$0.38 |
274.40K |
|
|
| Leap Therapeutics, Inc. is a biopharmaceutical company. Co. is focused on developing targeted and immuno-oncology therapeutics. Its advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-related protein 1 (DKK1) protein. DKK1 is also a modulator of CKAP4/PI3K/AKT signaling. DKN-01 is being developed in patients with esophagogastric, gynecologic, and colorectal cancers. Its second clinical-stage program is FL-301, a humanized monoclonal antibody targeting Claudin18.2, being developed in patients with gastric and pancreatic cancer. It also has two preclinical antibody programs, FL-302 and FL-501. | |
|
Leap Therapeutics (LPTX) has the following price history information. Looking back at LPTX historical stock prices for the last five trading days, on June 13, 2025, LPTX opened at $0.41, traded as high as $0.44 and as low as $0.40, and closed at $0.41. Trading volume was a total of 163.00K shares. On June 16, 2025, LPTX opened at $0.41, traded as high as $0.41 and as low as $0.38, and closed at $0.39. Trading volume was a total of 219.80K shares. On June 17, 2025, LPTX opened at $0.41, traded as high as $0.41 and as low as $0.38, and closed at $0.38. Trading volume was a total of 294.70K shares. On June 18, 2025, LPTX opened at $0.38, traded as high as $0.41 and as low as $0.38, and closed at $0.39. Trading volume was a total of 163.80K shares. On June 20, 2025, LPTX opened at $0.40, traded as high as $0.40 and as low as $0.38, and closed at $0.38. Trading volume was a total of 274.40K shares.
LPTX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Leap Therapeutics shares, starting with a $10,000 purchase of LPTX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/26/2017 |
|
| End date: |
06/20/2025 |
|
| Start price/share: |
$84.70 |
|
| End price/share: |
$0.38 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.55% |
|
| Average Annual Total Return: |
-47.51% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$44.53 |
|
| Years: |
8.40 |
|
|
|
| Date |
Close |
| 06/13/2025 | $0.41 | | 06/16/2025 | $0.39 | | 06/17/2025 | $0.38 | | 06/18/2025 | $0.39 | | 06/20/2025 | $0.38 |
|
|
Free LPTX Email Alerts:
